We are live on ! Find out more
ZLAB icon

Zai Lab

166 hedge funds and large institutions have $1.8B invested in Zai Lab in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 60 increasing their positions, 61 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more call options, than puts

Call options by funds: $8.51M | Put options by funds: $6.7M

0.31% less ownership

Funds ownership: 6.25%5.94% (-0.31%)

2% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 61

2% less funds holding

Funds holding: 170166 (-4)

10% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 20

13% less capital invested

Capital invested by funds: $2.07B → $1.8B (-$269M)

33% less funds holding in top 10

Funds holding in top 10: 96 (-3)

Holders
166
Holders Change
-4
Holders Change %
-2.35%
% of All Funds
2.67%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.1%
New
18
Increased
60
Reduced
61
Closed
20
Calls
$8.51M
Puts
$6.7M
Net Calls
+$1.81M
Net Calls Change
-$4.42M

ZLAB Hedge Fund Activity: Q4 2022 in Review

166 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Zai Lab (ZLAB) for Q4 2022, worth a combined $1.8B — down 13% from $2.07B a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of ZLAB and 18 opened new positions — a net loss of 2 holders — while 61 trimmed existing stakes and 60 added.

The largest buyer was Paradigm Biocapital Advisors, opening a new position worth an estimated $16.3M. The largest seller was Janus Henderson Group, cutting an estimated $66.7M.

  • 166 institutional investors held Zai Lab (ZLAB) as of Q4 2022, down from 170 in Q3 2022.
  • Funds reported $1.8B of Zai Lab stock for Q4 2022, down 13% quarter-over-quarter.
  • 18 funds opened new Zai Lab positions in Q4 2022 and 20 closed out, a net change of -2 holders.
  • The largest Zai Lab buyer in Q4 2022 was Paradigm Biocapital Advisors, an estimated $16.3M added.
  • The largest Zai Lab seller in Q4 2022 was Janus Henderson Group, an estimated $66.7M sold.

Based on aggregated 13F filings for Q4 2022.